MALATARAS, P.; PALLIKARAKIS, N. Spin-off use of adverse events data: why and how. The case of FDA’s MAUDE. Global Clinical Engineering Journal, [S. l.], v. 1, n. 1, p. 9–23, 2018. DOI: 10.31354/globalce.v1i1.32. Disponível em: https://globalce.org/index.php/GlobalCE/article/view/32. Acesso em: 21 jan. 2025.